The Event Shaping the Future of Advanced Therapies
In November, 2026 we’ll be launching the inaugural Advanced Therapies World, an unmissable event uniting the biotech ecosystem across the region. Bringing global decision-makers together to unlock commercial, scientific and strategic opportunities across the Middle East’s advanced therapies landscape. Designed to accelerate innovation and foster collaboration, the week will gather stakeholders from government, industry, academia, and healthcare to shape the future of advanced therapies.
2026 Expected Numbers
A Platform for Progress
Over recent months, we’ve been privileged to engage in meaningful discussions with key organizations and authorities committed to advancing the biotech landscape in the Middle East. These include:
Research Hospitals, Government Ministries, Commissions and Authorities, International Pharma and Biotech. All will converge to support global acceleration of advanced therapies in the GCC and beyond.
When: 10-11 November, 2026
Shaping the Future of Advanced Therapies
Industry Networking
Local Perspectives
Insight into the unique challenges and opportunities within the Middle Eastern biotech ecosystem.
Download the Sponsorship Brochure
Our sponsorship opportunities are designed to position your brand at the forefront of innovation, with tailored packages that maximise engagement before, during, and after the event. Gain unparalleled visibility and connect with key decision-makers across the advanced therapies ecosystem.
Everything you need to know about exhibiting, sponsorship packages, and who you’ll meet - right at your fingertips!
Key Themes at Advanced Therapies World 2026
Advanced Therapies World 2026 in Riyadh brings together global and regional leaders to explore the most pressing opportunities, innovations, and challenges shaping the future of cell and gene therapies. Across three days of curated content, hands-on showcases, and strategic networking, the event will focus on the themes driving progress across the advanced therapies ecosystem.
Localisation of Advanced Therapies Manufacturing
A cornerstone in Saudi Arabia’s National Biotechnology Strategy is to establish local end-to-end biomanufacturing capacity. Explore how international biotech firms can partner to establish sustainable operations, transfer technology, and unlock growth in this rapidly emerging market.
Infrastructure, Talent & Workforce Development
From world-class R&D hubs to specialised training programmes, the Kingdom cultivates the infrastructure and expertise needed to power its biotech future. Explore initiatives designed to develop a skilled workforce and create an integrated ecosystem for sustainable growth.
Clinical Translation & Hospital-Based Manufacturing
With healthcare transformation at its core, Saudi Arabia advances clinical translation through hospital-based manufacturing and earlystage trials. Discover how these models can bridge research and patient access, ensuring safety, scalability, and clinical impact.
Regulatory Pathways & Quality Systems for CGT in KSA
Hear directly from regulators and policy-makers on harmonising approvals, building consistent GMP frameworks, and enabling safe, equitable delivery of advanced therapies across diverse markets.
Investment & Public Private Partnerships
Saudi Arabia is catalysing a dynamic investment landscape for advanced therapies. Learn how strategic public–private partnerships and targeted initiatives are accelerating innovation, enabling tech transfer, and building investor confidence across the CGT value chain.
Real Experiences. Lasting Impact.
Have Any Questions?

If you have any questions, please don’t hesitate to contact us—we’re here to help!
Who is Advanced Therapies World for?
Advanced Therapies World is a focused conference and networking event for the advanced therapies and regenerative medicine community. It brings together key people across Global biotech and life sciences to discuss innovation, investment and bringing new treatments to market.
The event will take place in November 2026 in Riyadh, Saudi Arabia.
If you work in cell and gene therapy, regenerative medicine, biotech investment or manufacturing, this event is designed for you. It is ideal for senior leaders, scientists, investors, regulators and solution providers involved in the future of advanced therapies in the Middle East.
Yes. The event is a great opportunity for early-stage companies to meet potential partners, investors and industry experts in a more personal and focused setting.
Unlike larger exhibitions, this event focuses on in-depth discussion, targeted networking and knowledge sharing. It is smaller and more selective, with around 600 senior attendees, designed to encourage meaningful conversations and connections.
Sessions explore a wide range of issues across the advanced therapies field, including clinical development, commercial strategy, regulatory planning, manufacturing, market access and patient involvement.
Yes. The event includes a one-to-one partnering system so you can arrange meetings with potential collaborators, investors or clients before and during the event.
Yes. The event is built to help you meet deal makers, funders and biotech leaders from across the sector. It is a valuable chance to connect with people who influence the direction of advanced therapies.
You can register your interest in attending online here.
Yes. You will get travel and hotel information in your registration pack and email updates.
